Abstract:Graphical representation of the widespread white matter (blue color mask) and grey matter (cortical and deep grey matter; red color mask) demyelination in MS cases characterized by substantial inflammation of the CP (A). The presence of lesions was mainly associated with periventricular white matter and hippocampus areas (A). Spearman correlation analysis (B) between CP inflammation and the other quantified neuropathological parameters shows significant positive correlation (darker red) between degree of CP inflammation and degree of perivascular inflammation (R: 0.509, p: 7.921 × 10−4), with meningeal inflammation (R: 0.365, p: 0.021) and with the number of active lesions (R: 0.51, p: 3.524 × 10−5) identified in the surrounding periventricular areas (B). Extensive subependymal active demyelination (C) with intense microglia activation, characterized by expression of MHC‐class II, TMEM119, CD163, and iNOs (D–H) were detected in the hippocampus. Spearman correlation analysis between degree of CP inflammation and clinical features of the examined MS cases did not reveal any significant correlation (I). Survival analysis that compared the populations with (red line) and without (blue line) CP inflammation, with respect to the age at death did not found significantly difference (p: 0.391), even if a higher percentage of subjects without CP inflammation were characterized by later age at death (J). Scale bars: 500 μm (C), 200 μm (D),100 μm (E–I). Among the intrathecal inflammatory niches where compartmentalized inflammation persists and plays a pivotal role in progressive multiple sclerosis (MS), choroid plexus (CP) has recently received renewed attention. To better characterize the neuropathological/molecular correlates of CP in progressive MS and its potential link with other brain inflammatory compartments, such as perivascular spaces and leptomeninges, the levels, composition and phenotype of CP immune infiltration in lateral ventricles of the hippocampus were examined in 40 post‐mortem pathologically confirmed MS and 10 healthy donors, using immunochemistry/immunofluorescence and in‐situ sequencing. Significant inflammation was detected in the CP of 21 out of the 40 MS cases (52%). The degree of CP inflammation was found correlated with: number of CP macrophages (R: 0.878, p = 1.012 x 10‐13) and high frequency of innate immune cells expressing the markers MHC‐class II, CD163, CD209, CD11c, TREM2 and TSPO; perivascular inflammation (R: 0.509, p = 7.921 x 10‐4), and less with meningeal inflammation (R: 0.365, p = 0.021); number of active lesions (R: 0.51, p: 3.524 x 10‐5). However, it did not significantly correlate with any clinical/demographic characteristics of the examined population. In‐situ sequencing analysis of gene expression in the CP of 3 representative MS cases and 3 controls revealed regulation of inflammatory pathways mainly related to 'type 2 immune response', 'defense to infections', 'antigen processing/presentation'. Analysis of 78 inflammatory molecules in paired post‐mortem CSF, the levels of fibrinogen (R: 0.640, p = 8.752 x 10‐6), PDGF‐bb (R: 0.470, p = 0.002), CXCL13 (R: 0.428, p = 0.006) and IL15 (R: 0.327, p = 0.040) were correlated with extent of CP inflammation. Elevated fibrinogen and complement deposition were found in CP and in underlying subependymal periventricular areas, according to "surface‐in" gradient associated with concomitant prominent microglia activation. CP inflammation, predominantly characterized by innate immunity, represents another key determinant of intrathecal, compartmentalised inflammation persisting in progressive MS, which may be possibly activated by fibrinogen and influence periventricular pathology, even without substantial association with clinical features.

Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis

Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis

A-100 Selected pro-and anti-inflammatory cytokine serum concentrations in different clinical forms of multiple sclerosis

Neuropathological and cerebrospinal fluid correlates of choroid plexus inflammation in progressive multiple sclerosis

Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis

Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple Sclerosis.

Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes

Aberrant iron deposition in the multiple sclerosis spinal cord relates to neurodegeneration

Differential Expression of Complement Proteins in Cerebrospinal Fluid from Active Multiple Sclerosis Patients

Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.

Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy

Identification of brain-enriched proteins in CSF as biomarkers of relapsing remitting multiple sclerosis

The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology

Quantitative Proteomic Analysis of the Cerebrospinal Fluid of Patients with Multiple Sclerosis

Elevated expression of granulocyte-macrophage colony-stimulating factor receptor in multiple sclerosis lesions.

Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5

Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disorders

A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis

Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis

Proteomic analysis reveals dysregulation of peripheral blood neutrophils in patients with Multiple Sclerosis

Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis